Natera, Inc. (NTRA)
403.95
+2.58
(+0.64%)
USD |
NASDAQ |
Oct 23, 16:00
404.50
+0.55
(+0.14%)
After-Hours: 20:00
Natera Enterprise Value : 57.16B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 57.16B |
| October 22, 2026 | 56.79B |
| October 21, 2026 | 58.51B |
| October 20, 2026 | 57.44B |
| October 19, 2026 | 56.51B |
| October 16, 2026 | 55.65B |
| October 15, 2026 | 57.28B |
| October 14, 2026 | 55.84B |
| October 13, 2026 | 55.97B |
| October 12, 2026 | 56.27B |
| October 09, 2026 | 56.69B |
| October 08, 2026 | 55.27B |
| October 07, 2026 | 55.95B |
| October 06, 2026 | 56.69B |
| October 05, 2026 | 60.27B |
| October 02, 2026 | 58.08B |
| October 01, 2026 | 57.81B |
| September 30, 2026 | 58.50B |
| September 29, 2026 | 58.68B |
| September 28, 2026 | 58.28B |
| September 25, 2026 | 58.40B |
| September 24, 2026 | 57.85B |
| September 23, 2026 | 55.27B |
| September 22, 2026 | 55.28B |
| September 21, 2026 | 52.38B |
| Date | Value |
|---|---|
| September 18, 2026 | 52.20B |
| September 17, 2026 | 51.75B |
| September 16, 2026 | 48.74B |
| September 15, 2026 | 49.52B |
| September 14, 2026 | 48.23B |
| September 11, 2026 | 46.39B |
| September 10, 2026 | 45.98B |
| September 09, 2026 | 46.58B |
| September 08, 2026 | 45.70B |
| September 04, 2026 | 46.28B |
| September 03, 2026 | 46.20B |
| September 02, 2026 | 45.84B |
| September 01, 2026 | 45.21B |
| August 31, 2026 | 45.38B |
| August 28, 2026 | 46.00B |
| August 27, 2026 | 47.79B |
| August 26, 2026 | 47.75B |
| August 25, 2026 | 47.50B |
| August 24, 2026 | 46.21B |
| August 21, 2026 | 46.83B |
| August 20, 2026 | 45.80B |
| August 19, 2026 | 45.83B |
| August 18, 2026 | 43.91B |
| August 17, 2026 | 44.27B |
| August 14, 2026 | 43.66B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Guardant Health, Inc. | 23.23B |
| Myriad Genetics, Inc. | 651.69M |
| CareDx, Inc. | 3.209B |
| Caris Life Sciences, Inc. | 8.702B |
| BioRestorative Therapies, Inc. | -1.494M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -66.97M |
| Revenue (Quarterly) | 752.75M |
| Total Expenses (Quarterly) | 819.72M |
| EPS Diluted (Quarterly) | -0.4674 |
| Gross Profit Margin (Quarterly) | 63.70% |
| Profit Margin (Quarterly) | -8.90% |
| Earnings Yield | -0.34% |
| Normalized Earnings Yield | -0.334 |